臨床化學分析儀市場規模、佔有率、成長分析、按產品、按測試類型、按地區 - 產業預測，2024-2031 年

2022年全球臨床生化分析儀市場規模預計為128億美元，從2023年的134.5億美元成長到2031年的200.2億美元，預測期（2024-2031年）預計複合年成長率為5.1%。

由於診斷測試需求的增加和慢性病盛行率的增加，全球臨床化學分析儀市場正在顯著成長。這些分析儀對於測量生物樣本中的化學成分非常重要，特別是隨著人口老化增加糖尿病和心血管疾病等疾病的盛行率。技術進步，包括增強的演算法和自動化，進一步提高了準確性和效率，並提高了採用率。然而，高昂的初始成本和維護成本等挑戰可能會限制其使用，特別是在發展中地區的小型實驗室中。此外，檢查過程的複雜性和監管要求的嚴格性需要熟練的人員並遵守品質標準，這使相關人員的市場環境變得複雜。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特分析與影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 案例研究

臨床化學分析儀市場規模：依產品及複合年成長率（2024-2031）

• 試劑
  • 校準器
  • 控制
  • 標準
  • 其他
• 分析儀
  • 小型
  • 中等尺寸
  • 大的
  • 特大號
• 其他產品

臨床化學分析儀市場規模：按測試類型和複合年成長率（2024-2031）

• 基礎代謝組
• 肝臟組
• 腎臟面板
• 血脂譜
• 甲狀腺功能檢查
• 電解質板
• 特殊化學測試

臨床化學分析儀市場規模：依最終用戶和複合年成長率（2024-2031）

• 醫院和診所
• 診斷實驗室
• 實驗室/研究機構
• 其他最終用戶

臨床化學分析儀市場規模：按地區及複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Thermo Fisher Scientific, Inc.
• Danaher Corporation（Beckman Coulter）
• Abbott
• Siemens Healthineers AG
• F. Hoffmann-La Roche Ltd
• HORIBA, Ltd.
• QuidelOrtho Corporation
• Randox Laboratories Ltd
• Hitachi Ltd.
• EKF Diagnostics
• Sysmex Corporation
• Mindray Medical International
• Biobase Group
• SFRI
• Trivitron Healthcare Pvt. Ltd.
• Randox Laboratories Ltd
• Medica Corporation

結論和建議

Global Clinical Chemistry Analyzers Market size was valued at USD 12.8 billion in 2022 and is poised to grow from USD 13.45 billion in 2023 to USD 20.02 billion by 2031, growing at a CAGR of 5.1% during the forecast period (2024-2031).

The global clinical chemistry analyzers market has seen substantial growth, largely fueled by rising diagnostic test demand and the increasing prevalence of chronic diseases. These analyzers are critical in measuring chemical components in biological samples, especially as the elderly population grows, leading to heightened incidences of conditions like diabetes and cardiovascular diseases. Technological advancements, including enhanced algorithms and automation, have further improved their accuracy and efficiency, promoting wider adoption. However, challenges such as high initial and maintenance costs can restrict access for smaller laboratories, particularly in developing regions. Additionally, the complexity of the testing process and stringent regulatory requirements necessitate skilled personnel and adherence to quality standards, complicating the market landscape for stakeholders.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Chemistry Analyzers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Chemistry Analyzers Market Segmental Analysis

Global Clinical Chemistry Analyzers Market is segmented by Product, Test Type, End User and Region. Based on Product, the market is segmented into Reagents, Analyzers, Other Products. Based on Test Type, the market is segmented into Basic Metabolic Panels, Liver Panels, Renal Panels, Lipid Profiles, Thyroid Function Panels, Electrolyte Panels, Specialty Chemical Tests. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Research Laboratories & Institutes, Other End Users. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Driver of the Global Clinical Chemistry Analyzers Market

One of the primary catalysts for growth in the Global Clinical Chemistry Analyzers market is the surging prevalence of chronic diseases, including diabetes, cardiovascular ailments, and renal disorders. As these health issues become more widespread, there is an increased need for accurate diagnostics and ongoing monitoring, which clinical chemistry analyzers facilitate. These sophisticated devices are essential for testing and analyzing biological samples, thereby enhancing the ability to track disease progression and treatment efficacy. Consequently, the escalating incidence of these conditions significantly fuels the demand for advanced clinical chemistry analyzers, marking a pivotal trend in the market's development.

Restraints in the Global Clinical Chemistry Analyzers Market

The global clinical chemistry analyzers market faces significant constraints due to stringent regulatory requirements and quality control measures. Adhering to these regulations can prove to be complex and time-consuming, which adds to the overall costs associated with product development and commercialization. Manufacturers often encounter challenges in navigating the regulatory landscape, leading to delays in bringing new products to market. Consequently, the intricate compliance process can hinder innovation and result in increased financial burdens, ultimately stifling growth potential within the clinical chemistry analyzers sector. These challenges underline the need for efficient strategies to streamline compliance efforts while ensuring product safety and efficacy.

Market Trends of the Global Clinical Chemistry Analyzers Market

The Global Clinical Chemistry Analyzers market is witnessing a significant trend towards point-of-care testing (POCT), fueled by the rising demand for rapid diagnostic results and the shift towards decentralized testing environments. As healthcare systems increasingly prioritize timely decision-making, compact and portable clinical chemistry analyzers are being embraced for their capability to facilitate on-site testing. This trend enhances the efficiency of healthcare delivery, enabling providers to promptly diagnose and treat conditions, thereby improving patient outcomes. The growing emphasis on personalized medicine and efficient healthcare services further bolsters the expansion of POCT, positioning it as a key driver of market growth in the clinical chemistry sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Clinical Chemistry Analyzers Market Size by Product & CAGR (2024-2031)

• Reagents
  • Calibrators
  • Controls
  • Standards
  • Others
• Analyzers
  • Small
  • Medium
  • Large
  • Very Large
• Other Products

Global Clinical Chemistry Analyzers Market Size by Test Type & CAGR (2024-2031)

• Basic Metabolic Panels
• Liver Panels
• Renal Panels
• Lipid Profiles
• Thyroid Function Panels
• Electrolyte Panels
• Specialty Chemical Tests

Global Clinical Chemistry Analyzers Market Size by End User & CAGR (2024-2031)

• Hospitals and Clinics
• Diagnostic Laboratories
• Research Laboratories & Institutes
• Other End Users

Global Clinical Chemistry Analyzers Market Size by Region & CAGR (2024-2031)

• North America, (by Product, by Test Type, by End User)
  • US
  • Canada
• Europe, (by Product, by Test Type, by End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (by Product, by Test Type, by End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (by Product, by Test Type, by End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (by Product, by Test Type, by End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (Beckman Coulter)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HORIBA, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd
• Hitachi Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biobase Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SFRI
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trivitron Healthcare Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation